....
Pressemeldung

First vaccinee enrolled in a large phase III trial against tuberculosis in a Pan-African setting

Vakzine Projekt Management GmbH (VPM) announces that the first participant has been enrolled in a large phase III trial to assess the efficacy and safety of the novel TB vaccine – VPM1002 - in comparison with BCG in healthy newborn infants. Read more!

powered by webEdition CMS